
    
      OUTLINE: This is a 4 arm, multi-center study.

      Sample Collection:

        -  Core Biopsy

        -  Serum

        -  Urine

      Treatment Regimens (Investigator/Patient Discretion):

        -  Arm A: Doxorubicin 60 mg/m2 + Cyclophosphamide 600 mg/m2 day 1 of every 21-day cycle

        -  Arm B: Capecitabine 1000 mg/m2 BID days 1-14 of every 21-day cycle

        -  Arm C: Vinorelbine 25 mg/m2 days 1, 8, 15 of every 28-day cycle

        -  Arm D: Gemcitabine 1000 mg/m2 days 1, 8, 15 of every 28-day cycle

      Performance status & Organ Function:

      Performance status and organ function appropriate for chemotherapy in the opinion of the
      treating investigator according to Good Clinical Practice (GCP).

      Life Expectancy: Not specified

      Hematopoietic: Not specified

      Hepatic: Not specified

      Renal: Not specified

      Cardiovascular: Not specified

      Pulmonary: Not specified
    
  